$New to paradigm for the treatment of heart failure with reduced ejection fraction?$

New to paradigm for the treatment of heart failure with reduced ejection fraction?

Bibliographic Details
Main Author:	Delfín Rodríguez Leyva
Format:	Article
Language:	Spanish
Published:	ECIMED 2015-04-01
Series:	Revista Cubana de Cardiología y Cirugía Cardiovascular
Online Access:	http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/581

Similar Items

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
by: Abdallah Al‐Mohammad
Published: (2019-08-01)

Distinguishing heart failure with preserved ejection fraction from heart failure with reduced ejection fraction using proteomics techniques
by: Mbasu, Richard Juma
Published: (2016)

Medical Treatment of Heart Failure with Reduced Ejection Fraction — Prognostic Indication
by: Giuseppe MC Rosano
Published: (2017-01-01)

Role of interleukins in heart failure with reduced ejection fraction
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01)

Prognostic Relevance of Anxiety in Distinct Phenotypes of Heart Failure:Heart Failurewith Reduced Ejection Fraction and Heart Failure with Preserved Ejection Fraction
by: HSU, BO-CHENG, et al.
Published: (2019)

Treatment of heart failure with preserved ejection fraction
by: Alfredo Monteverde, et al.
Published: (2018-06-01)

Medical Treatment of Heart Failure with Reduced Ejection Fraction — Aimed at Reducing Re-hospitalisations
by: Giuseppe MC Rosano
Published: (2017-01-01)

Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid-Range Ejection Fraction
by: Ewa A Jankowska, et al.
Published: (2017-01-01)

The ‘diamond’ approach to personalized drug treatment of heart failure with reduced ejection fraction
by: Hongbo Gan, et al.
Published: (2021-09-01)

Role of Vitamin D in heart failure with reduced ejection fraction
by: Dinkar Bhasin
Published: (2016-01-01)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
by: Daniele Masarone, et al.
Published: (2021-08-01)

Emerging Pharmacologic Therapies for Heart Failure With Reduced Ejection Fraction
by: Ammar G. Chaudhary, MBChB, FRCPC, et al.
Published: (2021-05-01)

NEW OPPORTUNITIES IN TREATMENT OF CHRONIC HEART FAILURE WITH NORMAL EJECTION FRACTION
by: A. G. Dushina, et al.
Published: (2015-08-01)

Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction
by: Tarek Bekfani, et al.
Published: (2021-08-01)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021-09-01)

ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION
by: E. V. Reznik, et al.
Published: (2018-03-01)

Comment on “Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction”
by: Mário Oliveira
Published: (2015-12-01)

Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction
by: Koichiro Matsumura, et al.
Published: (2020-12-01)

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
by: Roberta D'Assante, et al.
Published: (2021-04-01)

Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
by: Martin R Cowie, et al.
Published: (2021-06-01)

The prognostic value of altitude in patients with heart failure with reduced ejection fraction
by: Ahmet Kaya, et al.
Published: (2019-11-01)

Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
by: Ishan Lakhani, et al.
Published: (2019-07-01)

Role of iron carboxymaltose therapy in heart failure with reduced ejection fraction
by: V.K. Katyal, et al.
Published: (2017-11-01)

Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction?
by: Navjyot Kaur, et al.
Published: (2021-03-01)

Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in the Treatment of Heart Failure with Reduced Ejection Fraction
by: Ilaria Spoletini, et al.
Published: (2017-01-01)

Medical Treatment of Heart Failure with Reduced Ejection Fraction — Improving Clinical Status and Functional Capacity
by: Cristiana Vitale, et al.
Published: (2017-01-01)

Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
by: Krittayaphong R, et al.
Published: (2019-12-01)

SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction
by: José Silva-Cardoso, et al.
Published: (2021-09-01)

Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers
by: Madelaire C, et al.
Published: (2020-06-01)

New Classification for Heart Failure with Mildly Reduced Ejection Fraction : Greater clarity or more confusion?
by: Sunil Nadar
Published: (2017-02-01)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
by: Xinxin Zhang, et al.
Published: (2021-08-01)

Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)

Heart Failure With Preserved Ejection Fraction and Obesity
by: Arjun Sinha, MD, et al.
Published: (2020-01-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations
by: Alexandra Arvanitaki, et al.
Published: (2020-08-01)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
by: Christopher J. Charles, et al.
Published: (2020-10-01)

Clinical Utility of Exercise Training in Heart Failure with Reduced and Preserved Ejection Fraction
by: Muhammad Asrar Ul Haq, et al.
Published: (2015-01-01)

Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction
by: David Montero, et al.
Published: (2019-11-01)

Clinical Utility of Exercise Training in Heart Failure with Reduced and Preserved Ejection Fraction
by: Muhammad Asrar Ul Haq, et al.
Published: (2015-02-01)

Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
by: Jingmin Zhou, et al.
Published: (2020-02-01)

Cannot write session to /tmp/vufind_sessions/sess_dealolv86ificepkqlrl8j5oo4